Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F24015)

Formulation Name

Alpelisib 200mg tablet

Company

Novartis

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Alpelisib	DMEXMYK	Breast cancer	2C60-2C65	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cellulose microcrystalline	E00698	Not Available	Adsorbent; Suspending agent; Diluent
Ferric oxide black	E00522	16211978	Colorant
Haematite red	E00236	14833	Colorant
Hypromellose	E00634	Not Available	Coating agent
Magnesium stearate	E00208	11177	lubricant
Mannitol	E00103	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polyethylene glycol 4000	E00654	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Talc	E00520	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	E00322	26042	Coating agent; Colorant; Opacifying agent

--------------------